Steven Chang, M.S.
President, QSP Pittsburgh
Quantitative Systems Pharmacology
Mr. Chang is the President of Immunetrics, a modeling and simulation company recently acquired by Simulations Plus. He is a successful technology entrepreneur with more than three decades of experience in identifying emerging market needs and combining state of the art technologies and resources to meet those needs.
Mr. Chang has served as President and Chief Executive Officer of Immunetrics since 2002. Prior to that, from 1998 to 2001, he served as Chief Executive Officer of Futuristic Labs, Inc. His experience includes work in diverse markets such as power generation, transportation logistics, critical care medicine, pharmaceutical drug development, quantitative systems pharmacology, and mobile applications. He is the recipient of two Westinghouse Signature Awards of Excellence. Mr. Chang received a BS and an MS in Electrical Engineering from the Rensselaer Polytechnic Institute in New York.